Current status:
Cancelled Post Market
Current status date:
2018-06-06
Product name:
NOVO-RYTHRO ESTOLATE SUSPENSION
DIN:
00262595
Electronic product monograph is not available
Dosage form(s):
Suspension
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS):
See footnote 3
08:12.12.04
Anatomical Therapeutic Chemical (ATC):
See footnote 4
J01FA01 ERYTHROMYCIN
List of active ingredient(s)
Active ingredient(s) |
Strength |
ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE)
|
250 MG / 5 ML
|